Biochemical engineering

Mairin C. Rooney Joins SVB Leerink to Further Strengthen Biopharma Franchise

Retrieved on:

월요일, 8월 2, 2021

SVB Leerink, Financial services, Banking, Banks of the United States

Ms. Rooney joins SVB Leerink as a Senior Managing Director reporting to Global Co-Head of Healthcare Investment Banking, Dr. Dan Dubin.

Key Points:

Ms. Rooney joins SVB Leerink as a Senior Managing Director reporting to Global Co-Head of Healthcare Investment Banking, Dr. Dan Dubin.
"Mairin is a strong addition to the senior SVB Leerink team and broadens our leadership in the biopharma and life sciences sectors," Dr. Dubin stated.
Ms. Rooney brings over a decade of healthcare investment banking experience and joins SVB Leerink from Goldman Sachs where she served as Managing Director in the Healthcare Investment Banking group focused on biopharma and biotech clients.
SVB Leerink is a wholly owned subsidiary of SVB Financial Group and is a member of FINRA/SIPC.

Global Algal Oils Industry (2020 to 2027) - Key Market Trends and Drivers - ResearchAndMarkets.com

Retrieved on:

수요일, 6월 9, 2021

Retail, Alternative medicine, Health, Food, Beverage, Academic disciplines, Sustainable technologies, Algae fuel, Biochemical engineering, Bioreactors, Renewable energy, Sustainable energy, Compound annual growth rate, Dietary supplement, Algae, Sustainable development

The "Algal Oils - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points:

The "Algal Oils - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Dietary Supplements, one of the segments analyzed in the report, is projected to record a 14.1% CAGR and reach US$1.3 Billion by the end of the analysis period.
The U.S. Market is Estimated at $266 Million, While China is Forecast to Grow at 18.2% CAGR
The Algal Oils market in the U.S. is estimated at US$266 Million in the year 2020.
In the global Other End-Uses segment, USA, Canada, Japan, China and Europe will drive the 11.9% CAGR estimated for this segment.

Microwave Chemistry: Novel Methodologies to Increase Synthetic Yield, Purity and Efficiency, Upcoming Webinar Hosted by Xtalks

Retrieved on:

화요일, 4월 27, 2021

Natural sciences, Chemistry, Physical sciences, Chemical synthesis, Chemical reactions, Biochemical engineering, Chemical reaction engineering, Stoichiometry, Yield

However, this synthetic platform is not always utilized by chemists to its fullest extent.

Key Points:

However, this synthetic platform is not always utilized by chemists to its fullest extent.
Synthetic development is hindered by perceived limitations in what reaction conditions are possible.
Modern instrumentation can increase the scope of synthetic chemistry, improve yield and purity and significantly reduce reaction times.\nRegister for this webinar, which will provide a foundation for understanding microwave chemistry and introduce new technologies to address the limitations of former techniques.
Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.\nAyesha Rashid, Xtalks, +1 (416) 977-6555 x 272, [email protected]\n'

Seedo Corp. Appoints Dr. Efrat Greenwald As Chief Data Scientist

Retrieved on:

목요일, 4월 22, 2021

Musicians, Composers, Life sciences, Biotechnology, Biological engineering, Biochemical engineering, Bioreactor, Algae, Data-driven, Stochastic process, Seedo

b'TEL AVIV, Israel, April 22, 2021 /PRNewswire/ -- Seedo Corp. (OTCQB: SEDO), today announced the appointment of Dr. Efrat Greenwald as its Chief Data Scientist, in charge of developing growing protocol IP and analyzing information technology data systems.

Key Points:

b'TEL AVIV, Israel, April 22, 2021 /PRNewswire/ -- Seedo Corp. (OTCQB: SEDO), today announced the appointment of Dr. Efrat Greenwald as its Chief Data Scientist, in charge of developing growing protocol IP and analyzing information technology data systems.
She is uniquely qualified to lead Seedo\'s data science division successfully into the future."\nDr.
Greenwald focused her academic research on biological systems, developing a stochastic model for algae photosynthesis in bioreactors.
Data driven research can revive the agricultural industry and shift it from a capricious business model to one that is sustainable and reliable.

At 15.13% CAGR, Single-Use Bioreactor Market is expected to reach USD 4.50 Billion by 2027 Says Brandessence Market Research

Retrieved on:

수요일, 2월 24, 2021

Bioreactors, Life sciences, Biotechnology, Biology, Biochemical engineering, Biological engineering, Single-use bioreactor, Market segmentation, Vaccine, Membrane bioreactor, Hollow fiber bioreactor

Demand in Efficient Vaccines is a key driving factor for the growth of Single-Use Bioreactor Market.

Key Points:

Demand in Efficient Vaccines is a key driving factor for the growth of Single-Use Bioreactor Market.
The disposable bioreactor has a disposable bag instead of culture vessel which is known as Single-Use Bioreactor.
Single-Use Bioreactor Market Segmentation Analysis:
Global Single-Use Bioreactor Market report is segmented on the basis of construction, mode, sizes, applications and region & country level.
The major factors driving the growth of global Single-Use Bioreactor market is rising in demand of effective vaccines and medications.

At 15.13% CAGR, Single-Use Bioreactor Market is expected to reach USD 4.50 Billion by 2027 Says Brandessence Market Research

Retrieved on:

수요일, 2월 24, 2021

Bioreactors, Life sciences, Biotechnology, Biology, Biochemical engineering, Biological engineering, Single-use bioreactor, Market segmentation, Vaccine, Membrane bioreactor, Hollow fiber bioreactor

Demand in Efficient Vaccines is a key driving factor for the growth of Single-Use Bioreactor Market.

Key Points:

Demand in Efficient Vaccines is a key driving factor for the growth of Single-Use Bioreactor Market.
The disposable bioreactor has a disposable bag instead of culture vessel which is known as Single-Use Bioreactor.
Single-Use Bioreactor Market Segmentation Analysis:
Global Single-Use Bioreactor Market report is segmented on the basis of construction, mode, sizes, applications and region & country level.
The major factors driving the growth of global Single-Use Bioreactor market is rising in demand of effective vaccines and medications.

Two-third Single-use Bioprocess Systems Used for GMP and Commercial Production Applications: Persistence Market Research

Retrieved on:

수요일, 2월 10, 2021

Biotechnology, Biological engineering, Articles, Biochemical engineering, Bioreactor, Bioprocess, Science and technology, Technology

Besides, continuous focus by key players to manufacture high quality and technologically-advanced disposable bioprocess systems is also expected to accelerate market growth.

Key Points:

Besides, continuous focus by key players to manufacture high quality and technologically-advanced disposable bioprocess systems is also expected to accelerate market growth.
Increasing adoption of single-use bioprocess systems in biopharmaceutical companies is expected to result in remarkable revenue share of this segment.
Get Full Access of Report: https://www.persistencemarketresearch.com/checkout/12142
Key market players in the single-use bioprocess systems market are looking forward to expanding their manufacturing capacities by establishing new bioprocess facilities to meet global demand.
Persistence Market Research offers actionable insights and unique perspective on the single-use bioprocess systems market in its latest study, presenting historical demand assessment of 2015 2019 and projections for 20202030, based on component (bioreactors, mixers, bioprocess containers, transfer and storage bags, sampling systems, filtration systems, chromatography columns, probes & sensors, tubing assemblies, connectors & clamps, and filling systems), application (research & development (R&D) and GMP and commercial production), and end user (biopharmaceutical companies, contract research organizations, contract manufacturing organizations, and research institutes), across seven key regions of the world.

Two-third Single-use Bioprocess Systems Used for GMP and Commercial Production Applications: Persistence Market Research

Retrieved on:

수요일, 2월 10, 2021

Biotechnology, Biological engineering, Articles, Biochemical engineering, Bioreactor, Bioprocess, Science and technology, Technology

Besides, continuous focus by key players to manufacture high quality and technologically-advanced disposable bioprocess systems is also expected to accelerate market growth.

Key Points:

Besides, continuous focus by key players to manufacture high quality and technologically-advanced disposable bioprocess systems is also expected to accelerate market growth.
Increasing adoption of single-use bioprocess systems in biopharmaceutical companies is expected to result in remarkable revenue share of this segment.
Get Full Access of Report: https://www.persistencemarketresearch.com/checkout/12142
Key market players in the single-use bioprocess systems market are looking forward to expanding their manufacturing capacities by establishing new bioprocess facilities to meet global demand.
Persistence Market Research offers actionable insights and unique perspective on the single-use bioprocess systems market in its latest study, presenting historical demand assessment of 2015 2019 and projections for 20202030, based on component (bioreactors, mixers, bioprocess containers, transfer and storage bags, sampling systems, filtration systems, chromatography columns, probes & sensors, tubing assemblies, connectors & clamps, and filling systems), application (research & development (R&D) and GMP and commercial production), and end user (biopharmaceutical companies, contract research organizations, contract manufacturing organizations, and research institutes), across seven key regions of the world.

Aizon Launches GxP AI Bioreactor Application for the Pharma Industry to Scale Manufacturing & Quality

Retrieved on:

월요일, 2월 1, 2021

Aizon launches its Bioreactor Application, the pharma industrys first predictive analysis and deep knowledge management application.

Key Points:

Aizon launches its Bioreactor Application, the pharma industrys first predictive analysis and deep knowledge management application.
The Aizon Bioreactor Application adds the bioreactor process to the Smart Manufacturing transformation that is accelerating across the Pharma and Biotech industry.
Designed to work with both continuous and fed-batch bioreactors, the Aizon Bioreactor Application provides a deep understanding of the customers bioprocess manufacturing lifecycle.
AI models for bioreactor analytics are ready for use within the application or can be configured by customers within the GxP cloud-based application.

Smart Manufacturing Meets the Bioreactor: Driving More Value and Consistency from Bioprocessing, Upcoming Webinar Hosted by Xtalks

Retrieved on:

목요일, 1월 28, 2021

Life sciences, Pharmaceutical industry, Biochemical engineering, Articles, Biological engineering, Bioreactor, Biotechnology, Critical process parameters

To this end, pharma manufacturing teams have been mandated with improving bioreactor process consistency, maximizing productivity, and increasing right first time (RFT) critical process parameters (CPPs).

Key Points:

To this end, pharma manufacturing teams have been mandated with improving bioreactor process consistency, maximizing productivity, and increasing right first time (RFT) critical process parameters (CPPs).
The complexity of bioreactor data that influence these KPIs which include hundreds of simultaneous parameters poses significant analytical and data management challenges.
The Aizon Bioreactor Application is the industry's first AI-driven analytical and GxP data management application designed specifically for bringing smart manufacturing to the bioreactor.
For more information, or to register for this event, visit Smart Manufacturing Meets the Bioreactor: Driving More Value and Consistency from Bioprocessing.